Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging

Published:2011-08-26 Issue:1 Volume:90 Page:55-66
ISSN:0946-2716
Container-title:Journal of Molecular Medicine
language:en
Short-container-title:J Mol Med

Author:

Eckl Judith,Buchner Alexander,Prinz Petra U.,Riesenberg Rainer,Siegert Sabine I.,Kammerer Robert,Nelson Peter J.,Noessner Elfriede

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Drug Discovery,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00109-011-0806-7.pdf

Reference35 articles.

1. Moch H, Artibani W, Delahunt B, Ficarra V, Knuechel R, Montorsi F, Patard JJ, Stief CG, Sulser T, Wild PJ (2009) Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma. Eur Urol 56:636–643

2. Ficarra V, Galfano A, Mancini M, Martignoni G, Artibani W (2007) TNM staging system for renal-cell carcinoma: current status and future perspectives. Lancet Oncol 8:554–558

3. Gore ME, Larkin JM (2011) Challenges and opportunities for converting renal cell carcinoma into a chronic disease with targeted therapies. Br J Cancer 104:399–406

4. Wong MK (2008) The current role of immunotherapy for renal cell carcinoma in the era of targeted therapeutics. Curr Oncol Rep 10:259–263

5. Frankenberger B, Noessner E, Schendel DJ (2007) Immune suppression in renal cell carcinoma. Semin Cancer Biol 17:330–343

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TGF-β signalling limits effector function capacity of NK cell anti-tumour immunity in human bladder cancer;eBioMedicine;2024-06

2. Stemness related lncRNAs signature for the prognosis and tumor immune microenvironment of ccRCC patients;BMC Medical Genomics;2024-05-31

3. Dysfunctional natural killer cells can be reprogrammed to regain anti-tumor activity;The EMBO Journal;2024-04-18

4. Disulfidptosis status influences prognosis and therapeutic response in clear cell renal cell carcinoma;Aging;2024-01-24

5. Inhibitory receptors and checkpoints on NK cells: Implications for cancer immunotherapy;Pathology - Research and Practice;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3